Fusion enzymes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9399764
APP PUB NO 20130330780A1
SERIAL NO

13989084

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to recombinant proteins having N-acetylglucosaminyltransferase activity. The present disclosure further relates to methods for producing complex N-glycans including the steps of providing host cells containing such recombinant proteins and culturing the host cells such that the recombinant proteins are expressed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLYKOS FINLAND OYVIIKINKAARI 6 HELSINKI FI-00790

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hiltunen, Jukka Helsinki, FI 18 54
Huuskonen, Anne Helsinki, FI 23 42
Kanerva, Anne Helsinki, FI 31 117
Natunen, Jari Vantaa, FI 72 438
Saloheimo, Markku Helsinki, FI 37 78
Viskari, Heli Nummela, FI 3 7

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 26, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00